Legato Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,088
| Closed | -$669K | – | 595 |
|
|
2024
Q2 | $669K | Buy |
8,088
+614
| +8% | +$50.8K | 0.09% | 363 |
|
|
2024
Q1 | $638K | Buy |
7,474
+3,766
| +102% | +$321K | 0.08% | 384 |
|
|
2023
Q4 | $317K | Sell |
3,708
-5,381
| -59% | -$460K | 0.04% | 489 |
|
|
2023
Q3 | $814K | Buy |
9,089
+3,957
| +77% | +$354K | 0.12% | 291 |
|
|
2023
Q2 | $437K | Buy |
5,132
+2,265
| +79% | +$193K | 0.06% | 451 |
|
|
2023
Q1 | $237K | Sell |
2,867
-302
| -10% | -$25K | 0.04% | 431 |
|
|
2022
Q4 | $249K | Buy |
+3,169
| New | +$249K | 0.05% | 423 |
|
|
2018
Q1 | – | Sell |
-13,224
| Closed | -$768K | – | 160 |
|
|
2017
Q4 | $768K | Hold |
13,224
| – | – | 0.11% | 170 |
|
|
2017
Q3 | $593K | Hold |
13,224
| – | – | 0.09% | 190 |
|
|
2017
Q2 | $522K | Buy |
13,224
+11,888
| +890% | +$469K | 0.22% | 119 |
|
|
2017
Q1 | $54K | Hold |
1,336
| – | – | 0.06% | 63 |
|
|
2016
Q4 | $53.7K | Buy |
+1,336
| New | +$53.7K | 0.97% | 48 |
|